Results 201 to 210 of about 8,521 (239)

Thymidine phosphorylase in nucleotide metabolism: physiological functions and its implications in tumorigenesis and anti-cancer therapy. [PDF]

Front Immunol
Huang B, Yuan Q, Sun J, Wang C, Yang D.
europepmc   +1 more source

Are Procoagulant Platelets an Emerging Therapeutic Target? A General Review with an Emphasis on Their Clinical Significance in Companion Animals. [PDF]

Int J Mol Sci
Shaverdian M, Viall A, Li RHL.
europepmc   +1 more source

A review of natural compounds to regulate platelet aggregation: molecular mechanism and research advance. [PDF]

Front Pharmacol
Hou Y, Li H, Zhu L, Li Y, Zeng Y, Quan T, Xiang Z, Zhang Y, Bian Y, Wei Y.   +9 more
europepmc   +1 more source

Btk inhibition: the importance of being selective. [PDF]

Blood Adv
Flaumenhaft R.
europepmc   +1 more source

Unveiling the "Dark Matter" of platelet involvement in tumor microenvironment. [PDF]

J Pharm Anal
Zhang P, Zu R, Zhang X, Ren H, Rao L, Wang D, Li T, Leng P, Luo H.   +8 more
europepmc   +1 more source

Natural active herbal monomers for the treatment of thromboembolic diseases: a review. [PDF]

Front Pharmacol
Nie ZY, Zhang JQ, Shen YJ, Xi JQ, Cao YB, Zhang LC, Li L.   +6 more
europepmc   +1 more source

Editorial on Special Issue "State-of-Art in mRNA Therapeutics and Gene Delivery". [PDF]

Pharmaceutics
Mendonça LS.
europepmc   +1 more source

Beyond basic characterization and omics: Immunomodulatory roles of platelet-derived extracellular vesicles unveiled by functional testing. [PDF]

J Extracell Vesicles
Palviainen M, Puutio J, Østergaard RH, Eble JA, Maaninka K, Maaninka K, Butt U, Ndika J, Kari OK, Kamali-Moghaddam M, Kjaer-Sorensen K, Oxvig C, Aransay AM, Falcon-Perez JM, Federico A, Greco D, Laitinen S, Hayashi Y, Siljander PR.   +18 more
europepmc   +1 more source

Neutrophil recruitment depends on platelet-derived leukotriene B4. [PDF]

Blood Adv
Hackenbroch C, Cimen T, Gross C, Rubenzucker S, Burkard P, Groß N, Ahrends R, Girbl T, Stegner D.   +8 more
europepmc   +1 more source

Oroxylin A reverses SHP-2 oxidative inactivation in GPVI signaling to suppress platelet activation and thrombus formation. [PDF]

Thromb J
Chen Y, Lin Y, Hong J, Wang J, Li B, Liu Z, Ma Y, Sun X, Wang S, Li M, Wu M, Fu D, Li J, Wang M, Hu L.   +14 more
europepmc   +1 more source